Status:
RECRUITING
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Breast Cancer Metastatic
Eligibility:
FEMALE
18-99 years
Phase:
PHASE3
Brief Summary
DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer This is a prospective, monocentric, non-controlled, non-randomized, op...
Detailed Description
In women, breast cancer is the 1st largest cancer and accounted for 31% of new cancer cases in women in 2017. With 11,913 deaths in 2015, breast cancer is the 1st largest cancer death in women (19%) a...
Eligibility Criteria
Inclusion
- Age over 18
- Patients with metastatic breast cancer who have completed at least one first line of systemic therapy for metastatic breast cancer
- Patient labeled on the primary lesion ER+HER2- (20)
- Presence of metastatic liver and bone lesions identifiable with 18F-FDG PET-Scan
- Presence of at least 10 identifiable secondary lesions in 18F-FDG PET-Scan
- No therapeutic change between 18F-FDG PET-Scan and 68Ga-DOTATOC PET-Scan.
- Performing the PET scan with 68Ga-DOTATOC within a maximum of 21 days after the 18F-FDG PET-Scan
- Person affiliated to or benefiting from social security
- Person who has given written informed consent
Exclusion
- Patients followed or with history of other active neoplastic pathology (including neuroendocrine tumor)
- Known allergy to 68Ga-DOTATOC or its excipients
- Subject refusing to sign the consent to participate
- Minor subject
- Subject excluded from another study
- Persons referred to Articles L1121-5 to L1121-8 of the Public Health Code (CSP)
- Subject cannot be contacted in case of emergency
Key Trial Info
Start Date :
January 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06611891
Start Date
January 6 2025
End Date
October 1 2026
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, France, 38043